Sunday, October 22, 2023

Careful use of anthelminitcs can help limit resistance

 Recent research suggests that employing selective treatment regimens can significantly reduce the
development of anthelmintic resistance. This is particularly relevant in the context of parasites such as the cyathostomins (small redworms), which are among the most common internal parasites of horses. These parasites have developed resistance to various deworming drugs over the years due to their widespread and indiscriminate use.

In Sweden, a country known for its controlled approach to anthelmintic use, a study was conducted to investigate the presence of resistance to ivermectin, a commonly used deworming medication. The research found no evidence of resistance to ivermectin in cyathostomes in Sweden.

 

ML resistance has been observed in cyathostomins worldwide. However, the current situation in Sweden is unclear. Routine anthelmintic treatment of horses without prior diagnostic tests is rare in Sweden, since anthelmintic drugs were restricted to being available on prescription only in 2007. What effect would this have had on the development of ML resistance in the country?

 

To assess the effectiveness of deworming treatments, two common tests are used: the faecal egg count reduction test (FECRT) and the egg reappearance period (ERP) after treatment. FECRT evaluates whether a dewormer successfully reduces the number of internal parasite eggs in the horse's faeces. Samples are taken before treatment and around 10 to 14 days after deworming, and the two egg counts are compared. A high reduction percentage indicates that the dewormer is effective, while a low reduction percentage suggests potential resistance.

 

As internal parasites develop resistance to dewormers, the egg reappearance period (ERP) shortens, meaning that eggs reappear in the faeces more quickly after treatment.

 

A study led by Ylva Hedberg Alm and her colleagues aimed to assess FECRTs and ERPs following ivermectin (IVM) treatment in Swedish horses. Sixteen equestrian establishments, each with at least six horses excreting a minimum of 150 eggs per gram of faeces (EPG) during screening, were included in the study. FECRTs and ERPs were evaluated in faecal samples before and after IVM treatment (200 µg/kg) and for eight weeks afterward.

 

The questionnaire responses revealed that 69% of establishments administered anthelmintic treatments based on faecal diagnostics. All establishments achieved a high FECRT, exceeding 99.0%, and ERPs ranged from six to over eight weeks. Notably, younger horses were found to excrete cyathostomin eggs earlier after treatment than older horses.

 

The researchers also observed that riding schools, stud farms, and those not segregating summer and winter paddocks had shorter egg reappearance periods.

 

In conclusion, this study in Swedish equestrian facilities employing selective anthelmintic treatment revealed that the establishments maintained longer ERPs and showed no confirmed resistance to ivermectin. These findings support the use of selective deworming strategies as a means of reducing the risk of anthelmintic resistance in horses. The full report is available in Veterinary Parasitology.

 

For more details, see:

 

Retained efficacy of ivermectin against cyathostomins in Swedish horse establishments practicing selective anthelmintic treatment

Ylva Hedberg Alm, Eva Osterman Lind, Frida Martin, Rebecca Lindfors, Nina Roepstorff, Ulf Hedenström, Isabelle Fredriksson, Peter Halvarsson, Eva Tydén

Veterinary Parasitology (2023) Vol 322, 110007

 

https://doi.org/10.1016/j.vetpar.2023.110007

No comments: